Test cream made from cassia alata for skin rash
Part of Infections, Skin clinical trials.
This Phase 1 study tests how safe and how well a 20% cassia alata (a plant extract) cream works for tinea versicolor, a common skin condition. You may be able to join if your rash matches the study’s confirmed diagnosis and you have not used treatment recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 89 years old
- Have a skin rash that fits tinea versicolor, confirmed by skin scraping and stain test and/or a Wood’s lamp light exam
- Have not used any treatment for tinea versicolor in the last 4 weeks
- No known allergy to cassia alata (the plant extract)
- No known allergy to preservatives in creams/skin products
- Not be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a skin cream (clotrimazole) to a pill (itraconazole) to see which works better for treating pityriasis versicolor, a common fungal skin infection. If you have this condition and haven't used antifungal treatments recently, you may be able to join.
This study compares a 3-day course of ketoconazole shampoo to a 7-day course for treating tinea versicolor (a fungal skin condition that causes light or dark patches). Researchers want to see if the shorter treatment works as well as the longer one.
This trial tests two antifungal creams, Luliconazole and Ketoconazole, to see which works better for a common skin condition called pityriasis versicolor (also known as tinea versicolor) that causes light or dark patches on the skin.
This study compares two common antifungal pills, fluconazole and itraconazole, to see which works better for treating pityriasis versicolor, a skin condition that causes discolored patches. If you have this condition and are generally healthy, you may be able to join.
This study tests a cream called ruxolitinib for children with nonsegmental vitiligo. It aims to see if the cream can safely help restore skin color in affected areas.
This trial tests an ointment called MH004 to see if it helps repigment white patches in people with non-segmental vitiligo (the most common type). It focuses on patches on the face and body.
Hear when a new Pityriasis Versicolor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.